US drug approvals
153 approvals with a product on the US market
- Crisaborole ANDA216242 · approved 24 Sep 2026
- Milnacipran Hydrochloride ANDA210944 · approved 15 Sep 2026
- Sodium Sulfate, Potassium Sulfate And Magnesium Sulfate ANDA219429 · approved 31 Aug 2026
- Nintedanib Esylate ANDA219926 · approved 3 Aug 2026
- Dapsone ANDA218335 · approved 8 Jul 2026
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.